Herb Cross

This profile gathers the share dealings of Herb Cross across 4 companies, led by Facet Biotech Corp, Affymax Inc and Atreca, Inc. Over a trading history stretching from 14 September 2007 to 2 August 2023, the count stands at 26 filings.

On the market, this insider has only sold: 5 sales, €421k in total. Other entries cover 16 share grants and 3 option exercises. So far in 2023, the count stands at no purchases and 1 sale.

On 4 August 2023 came the latest disclosure, an open-market sale for €4,774 in Atreca, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.